Jacques Izopet to Prospective Studies
This is a "connection" page, showing publications Jacques Izopet has written about Prospective Studies.
Connection Strength
0.120
-
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. J Clin Virol. 2020 08; 129:104541.
Score: 0.036
-
A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces. J Clin Virol. 2018 08; 105:109-111.
Score: 0.031
-
The use of a multiplex real-time PCR assay for diagnosing acute respiratory viral infections in children attending an emergency unit. J Clin Virol. 2014 Nov; 61(3):411-7.
Score: 0.024
-
Use of two real-time polymerase chain reactions (PCRs) to detect herpes simplex type 1 and 2-DNA after automated extraction of nucleic acid. J Med Virol. 2004 Nov; 74(3):459-62.
Score: 0.012
-
Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
Score: 0.008
-
Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation. Transpl Infect Dis. 2018 Aug; 20(4):e12917.
Score: 0.008
-
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation. 1995 May 27; 59(10):1426-31.
Score: 0.002